SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-001851
Filing Date
2023-01-06
Accepted
2023-01-06 16:05:26
Documents
12
Period of Report
2022-12-31
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm232403d1_8k.htm   iXBRL 8-K 23119
  Complete submission text file 0001104659-23-001851.txt   188774

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA enzn-20221231.xsd EX-101.SCH 3024
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20221231_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20221231_pre.xml EX-101.PRE 22589
6 EXTRACTED XBRL INSTANCE DOCUMENT tm232403d1_8k_htm.xml XML 3185
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12957 | Film No.: 23515087
SIC: 2836 Biological Products, (No Diagnostic Substances)